Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
The Chinese-German Journal of Clinical Oncology
Metadata
Title
Anti-tumor effect of CTLs activated by dendritic cells pulsed with K-ras mutant peptide and whole tumor antigen on pancreatic cancer
Authors
Guang Tan
Zhongyu Wang
Xin Zhang
Zhengang Cai
Junkai Zhang
Publication date
01-12-2010
Publisher
Springer-Verlag
Published in
The Chinese-German Journal of Clinical Oncology / Issue 12/2010
Print ISSN: 1610-1979
Electronic ISSN: 1613-9089
DOI
https://doi.org/10.1007/s10330-010-0707-1

Other articles of this Issue 12/2010

The Chinese-German Journal of Clinical Oncology 12/2010 Go to the issue

OriginalPaper

The influence of interstitial brachytherapy with 125I seeds on Caspase-3 and Egr-1 expressions of Lewis lung carcinoma in C57BL mice

OriginalPaper

The clinical features of thoracic stomach cancer after surgical treatment for esophageal carcinoma

OriginalPaper

Capecitabine plus cisplatin treatment in patients with advanced hepatocellular carcinoma

OriginalPaper

BRCA1 and EGFR as prognostic biomarkers in triple negative metastatic breast cancer patients treated with cisplatin plus docetaxel

OriginalPaper

Wortmannin induced apoptosis of leukemia cells by reducing PI3K/Akt

OriginalPaper

The pooled analysis of single gemcitabine for non-small cell lung cancer patients with elderly age
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits